IRF3 and cancer: DNA-PK has been reported to be important for interferon regulatory factor 3 (IRF-3)-dependent innate immunity20,21; therefore, we demonstrated that inhibition of DNA-PK can attenuate the innate immune response and promote virus replication in cancer cells.